Market Cap

Hypera SA Market Capitalization:

R$17.53 Billion

BRL as of July 1, 2025

US$3.21 Billion

business Hypera SA Company Profile

Hypera SA Main Stock Listing

Bovespa: HYPE3

Market Capitalization History of Hypera SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $70.87 B
MERCK Kommanditgesellschaft auf Aktien $55.96 B
Takeda Pharmaceutical Company Limited $48.34 B
Haleon plc $46.46 B
Hansoh Pharmaceutical Group Company Ltd $23.59 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Hypera SA market cap

Date Market Cap YoY Change
Jan. 1, 2025 R$11.65 B -46.73%
Jan. 1, 2024 R$21.88 B -18.70%
Jan. 1, 2023 R$26.91 B 38.67%
Jan. 1, 2022 R$19.41 B -3.65%
Jan. 1, 2021 R$20.14 B -9.22%
Jan. 1, 2020 R$22.19 B 11.68%
Jan. 1, 2019 R$19.87 B -12.36%
Jan. 1, 2018 R$22.67 B 30.02%
Jan. 1, 2017 R$17.44 B 25.06%
Jan. 1, 2016 R$13.94 B 22.80%
Jan. 1, 2015 R$11.35 B 19.34%
Jan. 1, 2014 R$9.51 B -11.34%
Jan. 1, 2013 R$10.73 B 61.96%
Jan. 1, 2012 R$6.63 B -46.47%
Jan. 1, 2011 R$12.38 B -8.61%
Jan. 1, 2010 R$13.54 B 288.37%
Jan. 1, 2009 R$3.49 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Hypera SA Categories

Brazil languages Healthcare languages Drug Manufacturers—Specialty & Generic
Brazil Healthcare Brazil Drug Manufacturers—Specialty & Generic

Stocks & Indices

Hypera SA has the following listings and related stock indices.


Stock: Bovespa: HYPE3

Stock: XSTU: HM6A

Stock: OTC: HYPMY

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.